ZyVersa Therapeutics, Inc.
ZVSA
$0.20
$0.014.17%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -24.95M | -25.70M | -8.29M | -8.84M | -9.41M |
| Total Depreciation and Amortization | -- | 0.00 | 1.70K | 4.30K | 6.90K |
| Total Amortization of Deferred Charges | 57.20K | -- | -- | -- | -- |
| Total Other Non-Cash Items | 18.26M | 18.52M | 777.90K | 760.30K | 917.00K |
| Change in Net Operating Assets | 1.52M | 1.26M | 2.39M | 2.56M | 970.00K |
| Cash from Operations | -5.11M | -5.92M | -5.12M | -5.52M | -7.52M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.05M | 5.09M | 3.87M | 3.87M | 6.54M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.63M | 1.23M | 1.21M | 1.22M | -628.20K |
| Cash from Financing | 3.69M | 6.32M | 5.08M | 5.09M | 5.91M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.43M | 405.10K | -47.40K | -422.10K | -1.61M |